ReviewBiochemistry and biophysics reports2024

miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review.

Thanh Hoa Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.